Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2176140rdf:typepubmed:Citationlld:pubmed
pubmed-article:2176140lifeskim:mentionsumls-concept:C0010825lld:lifeskim
pubmed-article:2176140lifeskim:mentionsumls-concept:C0019693lld:lifeskim
pubmed-article:2176140lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:2176140lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:2176140lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:2176140lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:2176140lifeskim:mentionsumls-concept:C1979893lld:lifeskim
pubmed-article:2176140lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:2176140pubmed:issue3lld:pubmed
pubmed-article:2176140pubmed:dateCreated1991-2-14lld:pubmed
pubmed-article:2176140pubmed:abstractTextIn order to delineate the molecular pathogenesis of the increased susceptibility to CMV disease in HIV infection, the patterns of antigen responsiveness in HIV-infected and non-infected individuals were investigated. CMV was fractionated by SDS-PAGE and electroblotted onto nitrocellulose. Lymphoproliferative responses of healthy HIV-, CMV+ individuals and HIV+, CMV+ asymptomatic patients to a whole CMV antigen preparation and to 20 fractions of nitrocellulose-bound CMV were then compared. Three fractions of approximate molecular weight of 130-165, 65-75, and 55-65 kD appeared to contain the major T cell stimulating antigens for HIV-, CMV+ individuals. A statistically significant depression of responses to fractions containing antigens in the ranges of 130-165 kD and 55-65 kD but not to whole CMV was seen in HIV+ individuals compared with controls. In healthy controls, the sum of the proliferative responses as measured by 3H-thymidine uptake to these three major fractions was approximately equal to the response to a whole CMV antigen preparation, whereas it was less than half of this response in five out of six HIV+ subjects. When antibody activities to CMV antigens were analysed by immunoblotting of sera from the two subject groups and also sera of ARC and AIDS patients, a selective loss of reactivity was revealed in 10 out of 19 HIV+ subjects to a band of 26-28 kD whereas all 15 HIV-, CMV+ controls recognized this band. Serum IgG and IgM values were both significantly higher in HIV+ individuals than in controls. These findings suggest that specific lesions in the repertoire of immune responsiveness to CMV antigens occur in HIV+ individuals.lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:languageenglld:pubmed
pubmed-article:2176140pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:citationSubsetIMlld:pubmed
pubmed-article:2176140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176140pubmed:statusMEDLINElld:pubmed
pubmed-article:2176140pubmed:monthDeclld:pubmed
pubmed-article:2176140pubmed:issn0009-9104lld:pubmed
pubmed-article:2176140pubmed:authorpubmed-author:StrannegårdOOlld:pubmed
pubmed-article:2176140pubmed:authorpubmed-author:ConverseP JPJlld:pubmed
pubmed-article:2176140pubmed:authorpubmed-author:BrittonSSlld:pubmed
pubmed-article:2176140pubmed:authorpubmed-author:EhrnstAAlld:pubmed
pubmed-article:2176140pubmed:authorpubmed-author:FehnigerT ETElld:pubmed
pubmed-article:2176140pubmed:issnTypePrintlld:pubmed
pubmed-article:2176140pubmed:volume82lld:pubmed
pubmed-article:2176140pubmed:ownerNLMlld:pubmed
pubmed-article:2176140pubmed:authorsCompleteYlld:pubmed
pubmed-article:2176140pubmed:pagination559-66lld:pubmed
pubmed-article:2176140pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:meshHeadingpubmed-meshheading:2176140-...lld:pubmed
pubmed-article:2176140pubmed:year1990lld:pubmed
pubmed-article:2176140pubmed:articleTitleImmune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals.lld:pubmed
pubmed-article:2176140pubmed:affiliationDepartment of Infectious Diseases, Roslagstull Hospital, Karolinska Institute, Stockholm, Sweden.lld:pubmed
pubmed-article:2176140pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2176140pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176140lld:pubmed